NTT Venture Capital
VC Fund
Menlo Park, United States
NTT Venture Capital is a VC fund in Menlo Park focused on Software and Artificial Intelligence. Launched in 2019, NTTVC is an independent venture capital firm formed in collaboration with NTT. Leveraging a unique partnership-focused strategy and deep industry network, NTTVC unlocks doors to relationships that can help startups reach global scale. With its $500M inaugural fund, the firm invests broadly in technology startups of all stages andsectors, with an emphasis on the future of enterprise, digital health and innovations powered by AI, machine learning and data. NTTVC is headquartered in Silicon Valley.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 46%
- Fund size:
- $500M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NTT Venture Capital invests in
Stages NTT Venture Capital invests in
Countries NTT Venture Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Fay Hazaveh Costa
|
|||
Shekar Ayyar
|
|||
Investment Focus
Industry
- Software 10 (42%)
- Artificial Intelligence 5 (21%)
- Health Care 4 (17%)
- Cloud Computing 3 (13%)
- Machine Learning 3 (13%)
Stage
- Series A 7 (29%)
- Series B 6 (25%)
- Seed 4 (17%)
- Series C 4 (17%)
- Pre-Seed 1 (4%)
Country
- United States 13 (54%)
- India 1 (4%)
- Israel 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Fay Hazaveh Costa
Partner
|
Partner | Total investments: 2 | Find email | |
|
Shekar Ayyar
Venture Partner
|
Venture Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Anthropic
|
Anthropic conducts AI research and develops AI products, including the Claude AI model family. The company focuses on building AI for human well-being, emphasizing safety in its research, policy work, and product design. Anthropic offers various Claude models, such as Opus and Sonnet, for AI-powered applications and custom experiences, supportingcoding and AI agents. | $50B / Series H / May 28, 2026 | |
Seemplicity
|
Seemplicity offers single platform with cyber-security, risk reduction, remediation, automation and remediation workflow. | $50M / Series B / Aug 20, 2025 | |
Anumana
|
Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. The company focuses on enhancing cardiac care through innovative technology, providing tools that assist healthcare professionals in identifying potential heart issues. Anumana's platform extends beyond diagnostics, aiming to improvepatient outcomes throughout the entire continuum of cardiovascular care, including perioperative and acute settings. By utilizing machine learning techniques, Anumana aims to refine screening processes, making it easier for clinicians to detect heart diseases and intervene promptly. This approach contributes to more efficient healthcare delivery and better management of cardiovascular health. | Series C / Apr 24, 2025 | |
Isotopes AI
|
Isotopes AI is a technology company offering an enterprise AI assistant designed to transform how teams interact with their business data. Its core product, aidnn, functions as an AI coworker—powered by specialized, transparent agents—that embeds into existing organizational data systems and enables users to ask business questions in naturallanguage. Aidnn autonomously handles data discovery, cleaning, analysis, visualization, and ongoing alerts, enabling collaborative and actionable insights without moving data outside company environments. | $20M / Seed / Jan 21, 2025 | |
Neysa
|
Neysa enables companies to effectively capitalize on the potential of AI/ML for their business users and end clients. | $30M / Series A / Oct 22, 2024 | |
Eko Health
|
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detectearlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com. | $41M / Series D / Jun 05, 2024 | |
|
Neysa
|
Neysa enables companies to effectively capitalize on the potential of AI/ML for their business users and end clients. | $19.9M / Seed / Apr 10, 2024 | |
Spyderbat
|
Cloud Native Runtime Security from Spyderbat detects and stops attacks throughout your Software Development Lifecycle (SDLC). Secure your Linux VMs and Kubernetes clusters at runtime. Rapidly and securely iterate your workloads with an automated understanding of runtime behavior differences between builds and environments. Block attacks againstcloud-native workloads. Gain live and historic contextual views across your Kubernetes, containers, and VM environments to immediately understand the root cause of security and operational issues.With a highly scalable, cloud-native SaaS architecture, Spyderbat's Automatic Continuous Causal Context (A3C) Engine immediately assembles runtime activities into a visual map based on causal relationships for real time and historic views. The Spyderbat platform monitors every causal sequence of activities within and across your workloads and automatically surfaces threats using actionable intelligence from Spyderbat Labs. The map is fully searchable to crush your investigation time and root cause analysis with a contextual understanding of what is happening. Block attacks against known and unknown vulnerabilities and track attacker's moves across different user sessions, workloads, and long periods of time. Through Spyderbat’s supported integrations, automated actions, and documented APIs, weave Spyderbat’s workload behavior monitoring and blocking into your existing build practices and notification channels. See it for yourself! Visit Spyderbat.com to try out our previously captured scenarios or create your own on your own systems. | $10M / Series A / Oct 24, 2022 | |
|
Seemplicity
|
Seemplicity offers single platform with cyber-security, risk reduction, remediation, automation and remediation workflow. | $26M / Series A / May 31, 2022 | |
Celona
|
Celona accelerates the adoption of LTE and 5G wireless in the enterprise by taking advantage of the Citizens Broadband Radio Service (CBRS) spectrum in the United States. Its solution architecture is designed to automate the deployment of cellular wireless by enterprise IT organizations and managed service providers, and drastically simplify itsintegration with an enterprise IT network. Celona was born with the idea that a combination of 5G radio technology, edge computing, and machine learning software will fundamentally change how organizations work and do business. Its founding team members have been part of companies like Qualcomm, Aruba, Cisco and have built products spanning technologies from chipsets to systems to cloud-based software. | $60M / Series C / Mar 28, 2022 | |
| See all 24 investments → | |||
Co-Investors
Matrix Capital Management
5 deals together
Matrix
5 deals together
Mayo Clinic Ventures
5 deals together
Nexus Venture Partners
4 deals together
Artis Ventures
3 deals together
Highland Capital Partners
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does NTT Venture Capital invest in?
NTT Venture Capital invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series A and Series B stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact NTT Venture Capital?
Public channels for NTT Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NTT Venture Capital?
The team at NTT Venture Capital includes Fay Hazaveh Costa (Partner) and Shekar Ayyar (Venture Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
